Africa Large Volume Parenterals (LVP) Market by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Other), and Capacity (100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml) - Global Opportunity Analysis and Industry Forecast, 2018-2024
The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered 291,095 thousand units in 2017, and is expected to reach 582,780 thousand units by 2024, growing with a CAGR of 10.4% from 2018 to 2024.
Parenteral route of drug administration refers to the administration of drugs through non-oral routes. Large volume parenterals, also termed as large volume injections, are aqueous solutions usually supplied in volumes of at least 100 ml. They include calcium solutions, sodium chloride, ringer's, sodium bicarbonate & other electrolyte solutions, dextrose (glucose) & other sugar solutions, amino acid, peptide & other protein fraction solutions, solutions containing a combination of the above, sometimes with vitamins added, dextrans, and other plasma expanders.
Increase in prevalence of cancer, HIV, and other non-communicable diseases; rapid surge in number of surgeries; and rise in risk of malnutrition drive the growth of the Africa large volume parenterals (LVP) market. However, preference for enteral route of drug administration of therapeutic & nutritional needs and high risk of infection/allergic reaction during a parenteral administration impede the market growth. On the contrary, upsurge in demand for palliative care services in Africa is expected to offer opportunities for market expansion during the forecast period.
The report segments the Africa large volume parenterals market based on treatment type, route of administration, capacity, and country. On the basis of treatment type, the market is classified into fluid balance injections, therapeutic injections, and nutritious injections. Depending on route of administration, it is fragmented into intravenous, intramuscular, subcutaneous, and other routes. LVP are commercially available in 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles. Country wise, the market is analyzed across South Africa, Zimbabwe, Namibia, and rest of Africa.
KEY BENEFITS
By Treatment Type
Parenteral route of drug administration refers to the administration of drugs through non-oral routes. Large volume parenterals, also termed as large volume injections, are aqueous solutions usually supplied in volumes of at least 100 ml. They include calcium solutions, sodium chloride, ringer's, sodium bicarbonate & other electrolyte solutions, dextrose (glucose) & other sugar solutions, amino acid, peptide & other protein fraction solutions, solutions containing a combination of the above, sometimes with vitamins added, dextrans, and other plasma expanders.
Increase in prevalence of cancer, HIV, and other non-communicable diseases; rapid surge in number of surgeries; and rise in risk of malnutrition drive the growth of the Africa large volume parenterals (LVP) market. However, preference for enteral route of drug administration of therapeutic & nutritional needs and high risk of infection/allergic reaction during a parenteral administration impede the market growth. On the contrary, upsurge in demand for palliative care services in Africa is expected to offer opportunities for market expansion during the forecast period.
The report segments the Africa large volume parenterals market based on treatment type, route of administration, capacity, and country. On the basis of treatment type, the market is classified into fluid balance injections, therapeutic injections, and nutritious injections. Depending on route of administration, it is fragmented into intravenous, intramuscular, subcutaneous, and other routes. LVP are commercially available in 100 ml, 250 ml, 500 ml, 1000 ml, and 2000 ml bottles. Country wise, the market is analyzed across South Africa, Zimbabwe, Namibia, and rest of Africa.
KEY BENEFITS
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Analysis by route of administration helps to understand the various routes for administration of parenteral drugs within the body.
- Comprehensive analysis of major countries within Africa is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
By Treatment Type
- Fluid Balance Injections
- Therapeutic Injections
- Nutritious Injections
- Intravenous
- Intramuscular
- Subcutaneous
- Others
- 100 ml
- 250 ml
- 500 ml
- 1000 ml
- 2000 ml
- South Africa
- Zimbabwe
- Namibia
- Rest of Africa
- Abacus Parenteral Drugs Limited
- Erongo Med
- Datlabs Private Limited
- Addis Pharmaceuticals Factory PLC
- Pharmacure PLC
- Mascareignes Pharmaceutical Manufacturing Co. Ltd. (operates as a subsidiary of Parenteral Drug (India) Ltd.)
- Adcock Ingram Holdings Ltd.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top player positioning, 2016
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in number of surgical procedures
3.3.1.2. Rise in prevalence of chronic diseases
3.3.1.3. Rise in risk of malnutrition
3.3.2. Restraints
3.3.2.1. Risk of allergic reaction and infection
3.3.2.2. Preference for enteral route of administration
3.3.3. Opportunities
3.3.3.1. Upsurge in demand for palliative care
CHAPTER 4: AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Fluid balance injections
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Therapeutic Injections
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Nutritious injections
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Intravenous
5.2.1. Market size and forecast
5.3. Intramuscular
5.3.1. Market size and forecast
5.4. Subcutaneous
5.4.1. Market size and forecast
5.5. Other routes
5.5.1. Market size and forecast
CHAPTER 6: AFRICA LARGE VOLUME PARENTERALS MARKET, BY CAPACITY
6.1. Overview
6.1.1. Market size and forecast
6.2. 100 ml
6.2.1. Market size and forecast
6.3. 250 ml
6.3.1. Market size and forecast
6.4. 500 ml
6.4.1. Market size and forecast
6.5. 1000 ml
6.5.1. Market size and forecast
6.6. 2000 ml
6.6.1. Market size and forecast
CHAPTER 7: AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY
7.1. Overview
7.1.1. Market size and forecast
7.2. South Africa
7.2.1. Market size and forecast
7.3. Zimbabwe
7.3.1. Market size and forecast
7.4. Namibia
7.4.1. Market size and forecast
7.5. Rest of Africa
7.5.1. Market size and forecast
CHAPTER 8: COMPANY PROFILE
8.1. Parenteral Drugs (India) Ltd.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Adcock Ingram Holdings Ltd.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Pharmacure PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.4. Datlabs Private Limited
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. Erongo Med
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. Addis Pharmaceutical Factory PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. Abacus Parenteral Drugs Limited
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
1.1. Report description
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top player positioning, 2016
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in number of surgical procedures
3.3.1.2. Rise in prevalence of chronic diseases
3.3.1.3. Rise in risk of malnutrition
3.3.2. Restraints
3.3.2.1. Risk of allergic reaction and infection
3.3.2.2. Preference for enteral route of administration
3.3.3. Opportunities
3.3.3.1. Upsurge in demand for palliative care
CHAPTER 4: AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Fluid balance injections
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Therapeutic Injections
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Nutritious injections
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Intravenous
5.2.1. Market size and forecast
5.3. Intramuscular
5.3.1. Market size and forecast
5.4. Subcutaneous
5.4.1. Market size and forecast
5.5. Other routes
5.5.1. Market size and forecast
CHAPTER 6: AFRICA LARGE VOLUME PARENTERALS MARKET, BY CAPACITY
6.1. Overview
6.1.1. Market size and forecast
6.2. 100 ml
6.2.1. Market size and forecast
6.3. 250 ml
6.3.1. Market size and forecast
6.4. 500 ml
6.4.1. Market size and forecast
6.5. 1000 ml
6.5.1. Market size and forecast
6.6. 2000 ml
6.6.1. Market size and forecast
CHAPTER 7: AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY
7.1. Overview
7.1.1. Market size and forecast
7.2. South Africa
7.2.1. Market size and forecast
7.3. Zimbabwe
7.3.1. Market size and forecast
7.4. Namibia
7.4.1. Market size and forecast
7.5. Rest of Africa
7.5.1. Market size and forecast
CHAPTER 8: COMPANY PROFILE
8.1. Parenteral Drugs (India) Ltd.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Adcock Ingram Holdings Ltd.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Pharmacure PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.4. Datlabs Private Limited
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. Erongo Med
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. Addis Pharmaceutical Factory PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. Abacus Parenteral Drugs Limited
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
LIST OF TABLES
TABLE 01. TOTAL SURGICAL NEED IN SUB-SAHARAN AFRICA, 2010
TABLE 02. MINIMUM UNMET NEED FOR SURGICAL CASES IN SUB-SAHARAN AFRICA, 2010
TABLE 03. AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE, 2017-2024 ($MILLION)
TABLE 04. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
TABLE 05. OTHER ROUTES OF PARENTERAL ADMINISTRATION
TABLE 06. AFRICA LARGE VOLUME PARENTERALS VALUE MARKET, BY CAPACITY, 2017-2024 ($MILLION)
TABLE 07. AFRICA LARGE VOLUME PARENTERALS VOLUME MARKET, BY CAPACITY, 2017-2024 (THOUSAND UNITS)
TABLE 08. AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 09. PDIL: COMPANY SNAPSHOT
TABLE 10. PDIL: PRODUCT CATEGORY
TABLE 11. PDIL: PRODUCT PORTFOLIO
TABLE 12. ADCOCK INGRAM: COMPANY SNAPSHOT
TABLE 13. ADCOCK INGRAM: OPERATING SEGMENTS
TABLE 14. PHARMACURE: COMPANY SNAPSHOT
TABLE 15. DATLABS: COMPANY SNAPSHOT
TABLE 16. DATLABS: PRODUCT CATEGORY
TABLE 17. DATLABS: PRODUCT PORTFOLIO
TABLE 18. ERONGO MED: COMPANY SNAPSHOT
TABLE 19. ERONGO MED: PRODUCT CATEGORY
TABLE 20. ERONGO MED: PRODUCT PORTFOLIO
TABLE 21. APF: COMPANY SNAPSHOT
TABLE 22. APF: PRODUCT CATEGORY
TABLE 23. APF: PRODUCT PORTFOLIO
TABLE 24. APDL: COMPANY SNAPSHOT
TABLE 25. APDL: PRODUCT PORTFOLIO
TABLE 01. TOTAL SURGICAL NEED IN SUB-SAHARAN AFRICA, 2010
TABLE 02. MINIMUM UNMET NEED FOR SURGICAL CASES IN SUB-SAHARAN AFRICA, 2010
TABLE 03. AFRICA LARGE VOLUME PARENTERALS MARKET, BY TREATMENT TYPE, 2017-2024 ($MILLION)
TABLE 04. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
TABLE 05. OTHER ROUTES OF PARENTERAL ADMINISTRATION
TABLE 06. AFRICA LARGE VOLUME PARENTERALS VALUE MARKET, BY CAPACITY, 2017-2024 ($MILLION)
TABLE 07. AFRICA LARGE VOLUME PARENTERALS VOLUME MARKET, BY CAPACITY, 2017-2024 (THOUSAND UNITS)
TABLE 08. AFRICA LARGE VOLUME PARENTERALS MARKET, BY COUNTRY, 2017-2024 ($MILLION)
TABLE 09. PDIL: COMPANY SNAPSHOT
TABLE 10. PDIL: PRODUCT CATEGORY
TABLE 11. PDIL: PRODUCT PORTFOLIO
TABLE 12. ADCOCK INGRAM: COMPANY SNAPSHOT
TABLE 13. ADCOCK INGRAM: OPERATING SEGMENTS
TABLE 14. PHARMACURE: COMPANY SNAPSHOT
TABLE 15. DATLABS: COMPANY SNAPSHOT
TABLE 16. DATLABS: PRODUCT CATEGORY
TABLE 17. DATLABS: PRODUCT PORTFOLIO
TABLE 18. ERONGO MED: COMPANY SNAPSHOT
TABLE 19. ERONGO MED: PRODUCT CATEGORY
TABLE 20. ERONGO MED: PRODUCT PORTFOLIO
TABLE 21. APF: COMPANY SNAPSHOT
TABLE 22. APF: PRODUCT CATEGORY
TABLE 23. APF: PRODUCT PORTFOLIO
TABLE 24. APDL: COMPANY SNAPSHOT
TABLE 25. APDL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. AFRICA LVP MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. AFRICA LARGE VOLUME PARENTERALS MARKET FOR FLUID BALANCE INJECTIONS, 2017-2024 ($MILLION)
FIGURE 05. AFRICA LARGE VOLUME PARENTERALS MARKET FOR THERAPEUTIC INJECTIONS, 2017-2024 ($MILLION)
FIGURE 06. AFRICA LARGE VOLUME PARENTERALS MARKET FOR NUTRITIOUS INJECTIONS, 2017-2024 ($MILLION)
FIGURE 07. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 08. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAVENOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 09. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 10. AFRICA LARGE VOLUME PARENTERALS MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 11. AFRICA LARGE VOLUME PARENTERALS MARKET FOR OTHER ROUTES OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 12. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 100 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 13. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 250 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 14. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 500 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 15. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 1000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 16. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 2000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 17. SOUTH AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 18. ZIMBABWE LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 19. NAMIBIA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 20. REST OF AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 21. PDIL: NET SALES, 2014-2016 ($MILLION)
FIGURE 22. ADCOCK INGRAM: NET SALES, 2015-2017 ($MILLION)
FIGURE 23. ADCOCK INGRAM: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 01. AFRICA LVP MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. AFRICA LARGE VOLUME PARENTERALS MARKET FOR FLUID BALANCE INJECTIONS, 2017-2024 ($MILLION)
FIGURE 05. AFRICA LARGE VOLUME PARENTERALS MARKET FOR THERAPEUTIC INJECTIONS, 2017-2024 ($MILLION)
FIGURE 06. AFRICA LARGE VOLUME PARENTERALS MARKET FOR NUTRITIOUS INJECTIONS, 2017-2024 ($MILLION)
FIGURE 07. AFRICA LARGE VOLUME PARENTERALS MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 08. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAVENOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 09. AFRICA LARGE VOLUME PARENTERALS MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 10. AFRICA LARGE VOLUME PARENTERALS MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 11. AFRICA LARGE VOLUME PARENTERALS MARKET FOR OTHER ROUTES OF ADMINISTRATION, 2017-2024 ($MILLION)
FIGURE 12. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 100 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 13. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 250 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 14. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 500 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 15. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 1000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 16. AFRICA LARGE VOLUME PARENTERALS MARKET FOR 2000 ML BOTTLES, BY VALUE AND VOLUME, 2017-2024 ($MILLION)
FIGURE 17. SOUTH AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 18. ZIMBABWE LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 19. NAMIBIA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 20. REST OF AFRICA LARGE VOLUME PARENTERALS MARKET, 2017-2024 ($MILLION)
FIGURE 21. PDIL: NET SALES, 2014-2016 ($MILLION)
FIGURE 22. ADCOCK INGRAM: NET SALES, 2015-2017 ($MILLION)
FIGURE 23. ADCOCK INGRAM: REVENUE SHARE BY SEGMENT, 2017 (%)
